Syros Pharma, Global Blood team up to seek drugs for sickle cell disease
Under the agreement, Cambridge, Mass.-based Syros scientists will use genomic analysis to identify proteins called transcription factors.
Related Articles
‘We’ve vanished’: U.S. aid cuts leave health workers around the world reeling
The cuts to U.S. foreign aid could result in the resurgence of some diseases. They’ve also forced health workers out of their jobs.
Prime and Beam, born of same lab, pursuing rival gene-editing treatments
Prime Medicine and Beam Therapeutics had common origins in gene editing. Now they’re both pursuing treatments for the same disease.
RFK Jr. presses infant formula makers on seed oils, supply chain, and contaminants
FDA will review nutrients, increase testing for heavy metals and contaminants, explore development of updated formulas.
Texas public health official predicts the measles outbreak could take a year to contain
The director of public health for the city of Lubbock said Tuesday that uptake of the measles vaccine “has definitely been a struggle,” and that…
Congress created a unique plan to save rural hospitals — but few are using it
‘A stopgap to the hospital closure crisis’ has been used by only 38 facilities because of the strings attached.
NIH cancels funding for landmark diabetes study at a time of focus on chronic disease
The Trump administration has canceled funding for an ongoing 30-year, nationwide study tracking patients with prediabetes and diabetes, researchers said.
It’s Dr. Oz’s turn to tout AI on the Hill
In this edition of STAT’s Health Tech newsletter: Dr. Oz touting the benefits of AI for U.S. health care, and more.
Congress must reject taxing employer-provided health care coverage
Taxing employer-provided health care benefits for an extension of tax cuts could drastically increase the number of uninsured Americans.
A little-known HHS agency may face big layoffs
A little-known HHS agency may face big layoffs, FDA employees return to the office, and more in today’s D.C. Diagnosis newsletter.